Cathy Eng, MD, FACP GASTROINTESTINAL MEDICAL ONCOLOGY – MD Anderson discusses the Regorafenib Dose Optimization Study (ReDOS) and how a Weekly escalation Regorafenib 80 to 160 mg-day superior to start dose of 160 mg-day. Recorded at ASCO GI 2018.
Regorafenib Dose Optimization Study (ReDOS) Weekly escalation Regorafenib 80 to 160 mg-day superior to start dose of 160
